$PCT
PureCycle Technologies, Inc. Stock $pct

$pct Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000183003322000020 Filed on March 29, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$18.24M	$57.62M
YoY Change		105.98%
% of Gross Profit
Research & Development	$310.0K	$1.411M
YoY Change		117.75%
% of Gross Profit
Depreciation & Amortization	$774.0K	$2.300M
YoY Change		21.05%
% of Gross Profit
Operating Expenses	$21.88M	$69.58M	$850.0K
YoY Change	2474.0%	86.93%
Operating Profit
YoY Change
Interest Expense	-$930.0K	$6.652M	$10.00K
YoY Change	-9400.0%	62.01%
% of Operating Profit
Other Income/Expense, Net	$3.417M	-$7.922M
YoY Change		-49.77%
Pretax Income	-$19.39M	-$77.50M	-$840.0K
YoY Change	2208.57%	46.25%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$19.39M	-$77.50M	-$840.0K
YoY Change	2208.57%	46.25%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.75
Diluted Earnings Per Share	-$156.0K	-$0.75	-$100.6K
COMMON SHARES
Basic Shares Outstanding	125.0M shares	102.9M shares
Diluted Shares Outstanding		102.9M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$200.8M	$200.8M	$64.50M
YoY Change	211.29%	100291.0%
Cash & Equivalents	$33.42M	$33.42M	$64.50M
Short-Term Investments	$167.4M	$167.4M	$0.00
Other Short-Term Assets	$144.6M	$144.6M	$100.0K
YoY Change	144467.0%	131324.55%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$345.3M	$345.3M	$64.94M
YoY Change	431.81%	111302.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$225.2M	$225.2M	$74.07M
YoY Change	204.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$76.50M
YoY Change
Other Assets	$94.12M	$94.12M	$0.00
YoY Change
Total Long-Term Assets	$319.3M	$319.3M	$343.0M
YoY Change	-6.91%	317.27%
TOTAL ASSETS
Total Short-Term Assets	$345.3M	$345.3M	$64.94M
Total Long-Term Assets	$319.3M	$319.3M	$343.0M
Total Assets	$664.7M	$664.7M	$408.0M
YoY Change	62.92%	765.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.401M	$1.401M	$1.058M
YoY Change	32.42%	91.92%
Accrued Expenses	$35.53M	$1.532M	$26.94M
YoY Change	31.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$38.46M	$38.46M	$33.08M
YoY Change	16.28%	5168.36%
LONG-TERM LIABILITIES
Long-Term Debt	$232.5M	$232.5M	$0.00
YoY Change
Other Long-Term Liabilities	$1.069M	$12.18M	$1.000M
YoY Change	6.9%	354.55%
Total Long-Term Liabilities	$1.069M	$244.7M	$1.000M
YoY Change	6.9%	9030.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.46M	$38.46M	$33.08M
Total Long-Term Liabilities	$1.069M	$244.7M	$1.000M
Total Liabilities	$283.1M	$283.1M	$296.2M
YoY Change	-4.42%	8227.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$157.8M		-$80.71M
YoY Change	95.48%
Common Stock	$128.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$381.5M	$381.5M	$111.7M
YoY Change
Total Liabilities & Shareholders Equity	$664.7M	$664.7M	$408.0M
YoY Change	62.92%	765.02%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$19.39M	-$77.50M	-$840.0K
YoY Change	2208.57%	46.25%
Depreciation, Depletion And Amortization	$774.0K	$2.300M
YoY Change		21.05%
Cash From Operating Activities	-$12.55M	-$54.51M	-$10.00K
YoY Change	125390.0%	203.61%
INVESTING ACTIVITIES
Capital Expenditures	-$49.24M	-$137.4M
YoY Change		-560.85%
Acquisitions
YoY Change
Other Investing Activities	$16.80M	-$168.2M	$76.50M
YoY Change	-78.04%	119.85%
Cash From Investing Activities	-$32.44M	-$305.6M	$76.50M
YoY Change	-142.4%	925.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$695.0K
YoY Change		-100.65%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-708.0K	$293.4M	-76.99M
YoY Change	-99.08%	-22.43%
NET CHANGE
Cash From Operating Activities	-12.55M	-$54.51M	-10.00K
Cash From Investing Activities	-32.44M	-$305.6M	76.50M
Cash From Financing Activities	-708.0K	$293.4M	-76.99M
Net Change In Cash	-45.69M	-$66.72M	-500.0K
YoY Change	9038.6%	-120.19%
FREE CASH FLOW
Cash From Operating Activities	-$12.55M	-$54.51M	-$10.00K
Capital Expenditures	-$49.24M	-$137.4M
Free Cash Flow	$36.69M	$82.88M
YoY Change		-273.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001830033
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Business Days Prior To Notice Of Redemption DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodBusinessDaysPriorToNoticeOfRedemption	P3D
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-40234
CY2021	dei	Entity Registrant Name EntityRegistrantName	PureCycle Technologies, Inc.
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2293091
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	5950 Hazeltine National Drive
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 650
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32822
CY2021	dei	City Area Code CityAreaCode	877
CY2021	dei	Local Phone Number LocalPhoneNumber	648-3565
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	1500000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	163233680	shares
CY2021	dei	Auditor Firm AuditorFirmId	248
CY2021	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2021	dei	Auditor Location AuditorLocation	Chicago, Illinois
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33417000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64492000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	141855000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2712000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	446000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	345349000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	64938000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	88586000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	266082000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	5535000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	2890000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	225214000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74067000	USD
CY2021Q4	us-gaap	Assets Assets	664684000	USD
CY2020Q4	us-gaap	Assets Assets	407977000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1401000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1058000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35526000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26944000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1532000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4951000	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	122000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38459000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33075000	USD
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5000000	USD
CY2020Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	26477000	USD
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	232508000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	235676000	USD
CY2021Q4	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	6113000	USD
CY2020Q4	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1069000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1000000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	283149000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	296228000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	539423000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192381000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-237000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157779000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80714000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	381535000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	111749000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	664684000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	407977000	USD
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10554000	USD
CY2020	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8603000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1411000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	648000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57615000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27971000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	69580000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	37222000	USD
CY2021	us-gaap	Interest Expense InterestExpense	6652000	USD
CY2020	us-gaap	Interest Expense InterestExpense	4106000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1476000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	11554000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	206000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-110000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7922000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15770000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-77502000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-52992000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.96
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.96
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102913000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102913000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28732000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28732000	shares
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-237000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-77739000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-52992000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	111749000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	239000	USD
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	36000	USD
CY2021	pct	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	0	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	27900000	USD
CY2021	pct	Stock Issued During Period Value Reverse Recapitalization Net Of Redemptions And Issuance Costs StockIssuedDuringPeriodValueReverseRecapitalizationNetOfRedemptionsAndIssuanceCosts	293966000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	61796000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	USD
CY2021	pct	Adjustment To Additional Paid In Capital Warrants Exercised AdjustmentToAdditionalPaidInCapitalWarrantsExercised	196000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1695000	USD
CY2021	pct	Stock Reclassified During Period Value StockReclassifiedDuringPeriodValue	33000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22730000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-237000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-77502000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	381535000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2380000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	125676000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5626000	USD
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	16000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	31075000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-52992000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	111749000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-77502000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-52992000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	22636000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	5626000	USD
CY2021	pct	Non Cash Issuance Of Shares NonCashIssuanceOfShares	333000	USD
CY2020	pct	Non Cash Issuance Of Shares NonCashIssuanceOfShares	333000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1476000	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	11554000	USD
CY2021	us-gaap	Depreciation Depreciation	2281000	USD
CY2020	us-gaap	Depreciation Depreciation	1896000	USD
CY2021	us-gaap	Accretion Expense AccretionExpense	223000	USD
CY2020	us-gaap	Accretion Expense AccretionExpense	48000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2389000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	173000	USD
CY2021	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	109000	USD
CY2020	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	0	USD
CY2021	pct	Amortization Of Convertible Debt With Conversion Feature AmortizationOfConvertibleDebtWithConversionFeature	0	USD
CY2020	pct	Amortization Of Convertible Debt With Conversion Feature AmortizationOfConvertibleDebtWithConversionFeature	648000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-584000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2021	pct	Gain Loss On Warrants Exercised GainLossOnWarrantsExercised	0	USD
CY2020	pct	Gain Loss On Warrants Exercised GainLossOnWarrantsExercised	-211000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	314000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	2265000	USD
CY2020	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	-275000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	2645000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Royalties IncreaseDecreaseInPrepaidRoyalties	890000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-293000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	234000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9320000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	14725000	USD
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2801000	USD
CY2020	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	206000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5000000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54507000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17953000	USD
CY2021	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	137388000	USD
CY2020	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	26219000	USD
CY2021	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	0	USD
CY2020	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	3593000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	229183000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	37800000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	23196000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-305575000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29812000	USD
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	314000	USD
CY2021	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	91000	USD
CY2020	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	USD
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	12600000	USD
CY2021	pct	Payments For Advance To Affiliate Financing PaymentsForAdvanceToAffiliateFinancing	0	USD
CY2020	pct	Payments For Advance To Affiliate Financing PaymentsForAdvanceToAffiliateFinancing	2704000	USD
CY2021	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	91000	USD
CY2020	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	6142000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	13000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
CY2021	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	298461000	USD
CY2020	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	60000000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	480000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3358000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	244075000	USD
CY2021	pct	Payments Of Notes Issuance Costs PaymentsOfNotesIssuanceCosts	4067000	USD
CY2020	pct	Payments Of Notes Issuance Costs PaymentsOfNotesIssuanceCosts	8550000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	107170000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1695000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	196000	USD
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021	pct	Payments For Redemption Of Vested Investments PaymentsForRedemptionOfVestedInvestments	36000	USD
CY2020	pct	Payments For Redemption Of Vested Investments PaymentsForRedemptionOfVestedInvestments	16000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	293366000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	378189000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66716000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	330424000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	330574000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	150000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	263858000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	330574000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1495000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2141000	USD
CY2021	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	29797000	USD
CY2020	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	11893000	USD
CY2021	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	636000	USD
CY2020	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	0	USD
CY2021	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	1424000	USD
CY2020	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	3849000	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	61796000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	3492000	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4604000	USD
CY2020	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2021	pct	Stock Issued For Warrants StockIssuedForWarrants	0	USD
CY2020	pct	Stock Issued For Warrants StockIssuedForWarrants	18173000	USD
CY2021	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	USD
CY2020	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	31075000	USD
CY2021	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2020	us-gaap	Notes Issued1 NotesIssued1	1541000	USD
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2020	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	2646000	USD
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	25000000	shares
CY2021Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	250000000	USD
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares Maximum Issued DerivativeInstrumentContingentConsiderationLiabilitySharesMaximumIssued	4000000	shares
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2000000	shares
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod	P1Y
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Stock Price Trigger DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	employee
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	employee
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2000000	shares
CY2021Q1	pct	Adjustments To Additional Paid In Capital Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts	27900000	USD
CY2021Q1	pct	Business Combination Acquisition Related Costs Advisory Legal And Accounting BusinessCombinationAcquisitionRelatedCostsAdvisoryLegalAndAccounting	5200000	USD
CY2021	pct	Business Combination Acquisition Related Costs General And Administrative BusinessCombinationAcquisitionRelatedCostsGeneralAndAdministrative	3200000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Net ReverseRecapitalizationMergerConsiderationNet	1156900000	USD
CY2021Q1	pct	Reverse Recapitalization Number Of Shares Transferred In Merger ReverseRecapitalizationNumberOfSharesTransferredInMerger	83500000	shares
CY2021Q1	pct	Reverse Recapitalization Shares Transferred In Merger Price Per Share ReverseRecapitalizationSharesTransferredInMergerPricePerShare	10.00
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Transferred ReverseRecapitalizationMergerConsiderationTransferred	835000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Revenue Bonds ReverseRecapitalizationMergerConsiderationRevenueBonds	249600000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Convertible Notes ReverseRecapitalizationMergerConsiderationConvertibleNotes	60000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Line Of Credit ReverseRecapitalizationMergerConsiderationLineOfCredit	314000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Related Party Promissory Note ReverseRecapitalizationMergerConsiderationRelatedPartyPromissoryNote	12000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Net ReverseRecapitalizationMergerConsiderationNet	1156914000	USD
CY2021	pct	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	76510000	USD
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000000	USD
CY2021	pct	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	28049000	USD
CY2021	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	298461000	USD
CY2021Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4600000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in prior periods have been reclassified to conform with the report classifications years ended December 31, 2021, noting the Company has reflected the reverse recapitalization pursuant to the Business Combination for all periods presented within the audited consolidated balance sheets and statements of stockholders’ equity.</span></div>
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33400000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64500000	USD
CY2021Q4	pct	Working Capital WorkingCapital	306900000	USD
CY2020Q4	pct	Working Capital WorkingCapital	31900000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157800000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80700000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-77500000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-53000000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	17100000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	5900000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, related disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses for the period presented. The Company's most significant estimates and judgments involve valuation of the Company's equity, including assumptions made in the fair value of equity-based compensation and the fair value of warrants it has issued to service providers. Although these estimates are based on management’s best knowledge of current events and actions that the Company may undertake in the future, actual results may be different from these estimates.
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	26477000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	192381000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80714000	USD
CY2021Q4	pct	Reverse Recapitalization Conversion Price Quotient ReverseRecapitalizationConversionPriceQuotient	1000	USD
CY2021Q4	pct	Reverse Recapitalization Conversion Price Equity Value Threshold ReverseRecapitalizationConversionPriceEquityValueThreshold	775000000	USD
CY2021Q4	pct	Reverse Recapitalization Conversion Price Equity Value Threshold ReverseRecapitalizationConversionPriceEquityValueThreshold	775000000	USD
CY2021Q4	pct	Reverse Recapitalization Conversion Price ReverseRecapitalizationConversionPrice	6.93
CY2020Q4	pct	Reverse Recapitalization Conversion Price Quotient ReverseRecapitalizationConversionPriceQuotient	1000	USD
CY2020Q4	pct	Reverse Recapitalization Conversion Price Adjusted Equity Value Percent ReverseRecapitalizationConversionPriceAdjustedEquityValuePercent	0.80
CY2020Q4	pct	Feedstock Supply Agreement Number Of Suppliers FeedstockSupplyAgreementNumberOfSuppliers	1	supplier
CY2020Q4	pct	Feedstock Supply Agreement Number Of Purchasers FeedstockSupplyAgreementNumberOfPurchasers	2	purchaser
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6975000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	16730000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	7570000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	218275000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	249550000	USD
CY2021Q4	pct	Common Stock Number Of Votes For Each Share Held CommonStockNumberOfVotesForEachShareHeld	1	vote
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127600000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127600000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127600000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127600000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	613000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28.90
CY2021	pct	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P7Y
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.90
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M15D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.41
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	pct	Class Of Warrant Or Right Fair Value Assumptions Expected Dividend Rate ClassOfWarrantOrRightFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5900000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	11.50
CY2021Q1	pct	Class Of Warrant Or Right Remaining Contractual Term ClassOfWarrantOrRightRemainingContractualTerm	P5Y
CY2021Q1	pct	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2021Q1	pct	Class Of Warrant Or Right Redemption Of Warrants Or Rights Written Notice Of Redemption Threshold ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsWrittenNoticeOfRedemptionThreshold	P30D
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Stock Price Trigger DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	employee
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	employee
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	0	USD
CY2020Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	78000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-77502000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-52992000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3307000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-77502000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-77502000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-56299000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-56299000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102913000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102913000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28732000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28732000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.96
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.96
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	230295000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5081000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	225214000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	76867000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2800000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	74067000	USD
CY2021	us-gaap	Depreciation Depreciation	2300000	USD
CY2020	us-gaap	Depreciation Depreciation	1900000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-77502000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-52992000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-77502000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52992000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-16275000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2677000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.035
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2973000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.038
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	pct	Effective Income Tax Reconciliation Change In Tax Status Percent EffectiveIncomeTaxReconciliationChangeInTaxStatusPercent	0
CY2021	pct	Effective Income Tax Reconciliation Warrant Expense And Other Permanent Items Amount EffectiveIncomeTaxReconciliationWarrantExpenseAndOtherPermanentItemsAmount	241000	USD
CY2021	pct	Effective Income Tax Reconciliation Warrant Expense And Other Permanent Items Percent EffectiveIncomeTaxReconciliationWarrantExpenseAndOtherPermanentItemsPercent	-0.003
CY2020	pct	Effective Income Tax Reconciliation Warrant Expense And Other Permanent Items Amount EffectiveIncomeTaxReconciliationWarrantExpenseAndOtherPermanentItemsAmount	0	USD
CY2020	pct	Effective Income Tax Reconciliation Warrant Expense And Other Permanent Items Percent EffectiveIncomeTaxReconciliationWarrantExpenseAndOtherPermanentItemsPercent	0
CY2021	pct	Effective Income Tax Reconciliation Change In Tax Status Amount EffectiveIncomeTaxReconciliationChangeInTaxStatusAmount	-4100000	USD
CY2021	pct	Effective Income Tax Reconciliation Change In Tax Status Percent EffectiveIncomeTaxReconciliationChangeInTaxStatusPercent	0.053
CY2020	pct	Effective Income Tax Reconciliation Change In Tax Status Amount EffectiveIncomeTaxReconciliationChangeInTaxStatusAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	15205000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.196
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-721000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.009
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3585000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	728000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	0	USD
CY2021Q4	pct	Deferred Tax Assets Interest Expense Limitation Carryforwards DeferredTaxAssetsInterestExpenseLimitationCarryforwards	10819000	USD
CY2020Q4	pct	Deferred Tax Assets Interest Expense Limitation Carryforwards DeferredTaxAssetsInterestExpenseLimitationCarryforwards	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	1107000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	306000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1090000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	788000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18423000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15205000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3218000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	2691000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	527000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3218000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15200000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	15200000	USD
CY2021Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	167602000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	237000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	117164000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	117100000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	50438000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	50265000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	167602000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021	pct	Debt Securities Held To Maturity Weighted Average Remaining Maturity DebtSecuritiesHeldToMaturityWeightedAverageRemainingMaturity	P0Y8M12D
CY2021	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1931000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1839000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9248000	USD
CY2020	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1506000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1830000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1877000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	18231000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	903000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	352000	USD
CY2021Q2	pct	Loss Contingency Number Of Class Actions LossContingencyNumberOfClassActions	2	classAction

Files In Submission

Name	View Source	Status
0001830033-22-000020-index-headers.html	Edgar Link	pending
0001830033-22-000020-index.html	Edgar Link	pending
0001830033-22-000020.txt	Edgar Link	pending
0001830033-22-000020-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pct-20211231.htm	Edgar Link	pending
pct-20211231.xsd	Edgar Link	pending
pct-20211231_cal.xml	Edgar Link	unprocessable
pct-20211231_def.xml	Edgar Link	unprocessable
pct-20211231_g1.jpg	Edgar Link	pending
pct-20211231_htm.xml	Edgar Link	completed
pct-20211231_lab.xml	Edgar Link	unprocessable
pct-20211231_pre.xml	Edgar Link	unprocessable
pct-form10xk2021ex211listo.htm	Edgar Link	pending
pct-form10xk2021ex231gtcon.htm	Edgar Link	pending
pct-form10xk2021ex41descri.htm	Edgar Link	pending
pct-form10xkexhibit3112021.htm	Edgar Link	pending
pct-form10xkexhibit3122021.htm	Edgar Link	pending
pct-form10xkexhibit3212021.htm	Edgar Link	pending
pct-form10xkexhibit3222021.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCT
PureCycle Technologies, Inc. Stock $pct

2021 Q4 Form 10-K Financial Statement

#000183003322000020 Filed on March 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT PureCycle Technologies, Inc. Stock $pct

2021 Q4 Form 10-K Financial Statement

#000183003322000020 Filed on March 29, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT
PureCycle Technologies, Inc. Stock $pct